Trinity Delta’s business is institutional quality issuer-paid equity research.

Our company coverage and past research notes can be accessed via the dedicated Company Pages below, or from our Research Library.

Allergy Therapeutics
Allergy Therapeutics is an international commercial biotechnology company focused on the treatment and diagnosis of allergies.
Read more
ANGLE
ANGLE is a world leading liquid biopsy company with sample to answer solutions based on its Parsortix CTC platform.
Read more
Arecor Therapeutics
Arecor, a revenue-generating clinical-stage drug developer, has an in-house and partnered pipeline of enhanced products and portfolio of technology partnerships enabled by its proprietary formulation platform Arestat.
Read more
Avacta
Avacta is a biopharma company developing novel cancer immunotherapies, and high performing diagnostics, based on its two proprietary platforms: Affimer and pre|CISION.
Read more
Futura Medical
Futura Medical is an R&D driven small pharma with a novel DermaSys transdermal delivery system and a pre-commercial product (MED3000) for erectile dysfunction.
Read more
HUTCHMED
HUTCHMED, a Hong Kong-based biopharmaceutical company, developing and commercialising innovative, highly selective oral therapies for oncology indications.
Read more
MaxCyte
MaxCyte has a patented flow electroporation platform for non-viral transfection of a wide array of cells. Key assets at several partners are gaining greater visibility and approaching material value-inflection points.
Read more
Redx Pharma
Redx Pharma is a UK-based clinical stage drug discovery company that specialises in developing highly specific small molecules for cancer and fibrosis based on its proven medicinal chemistry platform.
Read more
Scancell
Scancell is a clinical-stage immuno-oncology specialist developing innovative and flexible antibody (AvidiMab and GlyMab) and therapeutic vaccine platforms (Moditope, ImmunoBody).
Read more

Subscribe to our research

Please sign up here to be added to our distribution database. 

    © 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).